Join the Avycaz group to help and get support from people like you.
Avycaz News
Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
DUBLIN, March 18, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA)...
FDA Approves Avycaz (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
DUBLIN, Feb. 1, 2018 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Allergan's...
FDA Medwatch Alert: Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors
ISSUE: FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and avibactam) due to confusion about the drug strength...
Further information
Related condition support groups
Pneumonia, Kidney Infections, Urinary Tract Infection